Skip to main content
SpringerLink
Log in

A Novel Approach to Optimize and Formulate Fast Disintegrating Tablets for Nausea and Vomiting

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of this study was to optimize and formulate fast disintegrating tablets (FDTs) for nausea and vomiting using aminoacetic acid, carmellose and sodium alginate with enough mechanical strength. Ondansetron HCl (water soluble) or domperidone (water insoluble) drug were added to FDTs and their disintegration behaviour was evaluated. Plackett Burman Screening Design was used to screen the independent active process variables [concentration of aminoacetic acid (X 1), concentration of carmellose (X 2) and tablet crushing strength (X 3)] which were found to actively influence the dependent variables [disintegration time in the mouth (DT), wetting time (WT), and water absorption ratio (WAR)] for both the drugs. Also, the coefficients of active variables (DT, WT and WAR) of FDTs containing domperidone was found to be significantly different (P < 0.05) from the coefficients of active factors (X 1, X 2 and X 3) containing ondansetron HCl FDTs. Further, FDTs containing domperidone was prepared according to central composite design for estimating the effect of active factors (X 1, X 2, X 3) in extended spherical domain. The regression analysis of quadratic fit revealed that DT, WT and WAR were 98% correlated with active factors (X 1, X 2 or X 3). The optimized domperidone FDTs were further compared with superdisintegrants (croscarmellose sodium or crospovidone). The data revealed that optimized domperidone FDTs were better than domperidone FDTs containing croscarmellose or crospovidone. Hence, this novel excipients combination can be used for delivery of water insoluble drugs in place of superdisintegrants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. R. K. Chang, X. Guo, B. A. Burnside, and R. A. Couch. Fast dissolving tablets. Pharm. Technol. 24:52–59 (2000).

    CAS  Google Scholar 

  2. L. Mallet. Caring for the elderly patient. J. Am. Pharm. Assoc. 36:628 (1996).

    Google Scholar 

  3. H. Seager. Drug delivery products and the Zydis fast dissolving dosage. J. Pharm. Pharmacol. 50:375–382 (1998).

    PubMed  CAS  Google Scholar 

  4. S. R. Parakh, and A. V. Gothoskar. A review of mouth dissolving technologies. Pharm. Technol. 27:92–100 (2003).

    CAS  Google Scholar 

  5. S. Schiemeir, and P. C. Schmidt. Fast dispersible ibuprofen tablets. Eur. J. Pharm. Sci. 15:295–305 (2002).

    Article  Google Scholar 

  6. J. Fukami, A. Ozawa, Y. Yoshihashi, E. Yonemochi, and K. Terada. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: Evaluation of wetting and disintegration of tablet on the basis of surface free energy. Chem. Pharm. Bull. (Tokyo). 53:1536–1539 (2005).

    Article  CAS  Google Scholar 

  7. I. I. Salem, J. M. R. Lopez, and A. C. Galan. Ondansetron hydrochloride. In H. G. Brittain (ed.), Analytical Profiles of Drug Substances and Excipients, vol. 27, Academic, California, 2001, pp. 301–308.

    Chapter  Google Scholar 

  8. J. E. Hoover. Gastrointestinal and liver drugs. In: Hendrickson R (ed) Remington:The Science and Practice of Pharmacy, 21st edn, Lippincott Williams & Wilkins, USA, PA, 2006, p. 1311.

  9. J. Fukami, B. Yonemochi, Y. Yoshihashi, and K. S. Terada. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int. J. Pharm. 310:101–109 (2006).

    Article  PubMed  CAS  Google Scholar 

  10. U. S. Pharmacopoeia. USP 30-NF25, USP, Rockville, MD, 2007.

    Google Scholar 

  11. V. B. Sutariya, R. C. Mashru, M. G. Sankalia, and J. M. Sankalia. Preparation of rapidly disintegrating tablets of ondansetron hydrochloride by direct compression method. Ars. Pharm. 47:293–311 (2006).

    Google Scholar 

  12. G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu. The scope of experimental design. In G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu (eds.), Pharmaceutical Experimental Designs, Marcel Dekker, NewYork, 1999, p. 50.

    Google Scholar 

  13. X. Y. Bi, H. Sunada, Y. Yonezawa, and Danjo. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm. 25:571–581 (1999).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Panacea Biotech Ltd. (Lalru, India), Nayan Pharmaceuticals Ltd. (Patiala, India) and Ind-Swift Labs, (Chandigarh, India) for providing gift samples of superdisintegrants, domperidone and ondansetron HCl, respectively for this invstigation.

Author information

Authors and Affiliations

  1. Pharmaceutics Division, Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India, 147002

    Honey Goel, Nishant Vora & Vikas Rana

Authors
  1. Honey Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nishant Vora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vikas Rana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vikas Rana.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goel, H., Vora, N. & Rana, V. A Novel Approach to Optimize and Formulate Fast Disintegrating Tablets for Nausea and Vomiting. AAPS PharmSciTech 9, 774–781 (2008). https://doi.org/10.1208/s12249-008-9113-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9113-1

Key words

Search

Navigation